GGrantIndex
← Leaderboards

Feroz R Papa

University Of California San Francisco

$19,804,607
Attributed
$35,659,745
Total exposure
15
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.7M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$35,659,745 · 15

By mechanism

R01$21,304,754 · 8
U01$8,892,938 · 3
DP2$2,316,250 · 1
P01$2,112,193 · 1
K08$608,985 · 1
R21$424,625 · 1

Top collaborators

Most similar at University Of California San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Response

Research focus

ResponseProteinsEndoplasmic ReticulumPathway InteractionsCellsSmall MoleculeOutputSignal PathwayPhosphotransferasesEndoplasmic Reticulum StressRibonucleasesApoptosisSignal TransductionCessation Of LifePreventTranscription FactorMessenger RnaIntegral Membrane ProteinEndoribonucleasesInsulinMolecular ChaperonesPharmaceutical PreparationsPhysiologicalPrograms

Grant awards (67)

Driving next generation UPR inhibitory kinase inhibitors for T1D$816,325
U01 · FY2025 · DK · contact PI
Disease-modifying drugs for T2D through targeting the Unfolded Protein Response$667,957
R01 · FY2025 · DK · contact PI
Disease-modifying drugs for T2D through targeting the Unfolded Protein Response$683,334
R01 · FY2024 · DK · contact PI
Modulating intrinsic beta cell stress to block diabetes pathogenesis$642,131
R01 · FY2024 · DK · contact PI
Modulating intrinsic beta cell stress to block diabetes pathogenesis$668,886
R01 · FY2023 · DK · contact PI
Partial Antagonists of IRE1 RNase--'PAIR's--to treat Type 1 Diabetes$720,903
U01 · FY2022 · DK · contact PI
Interventional Targeting of the IRE1alpha-TGFbeta signaling loop in pulmonary fibrosis$697,743
R01 · FY2022 · HL
Modulating intrinsic beta cell stress to block diabetes pathogenesis$668,886
R01 · FY2022 · DK · contact PI
Role of the Unfolded Protein Response in Photoreceptor Degeneration$549,721
R01 · FY2022 · EY
Developing UPR inhibitory KIRAs into oral antidiabetic beta cell-sparing drugs$502,298
R01 · FY2022 · DK · contact PI
Partial Antagonists of IRE1 RNase—‘PAIR’s—to treat Type 1 Diabetes$726,915
U01 · FY2021 · DK · contact PI
Interventional Targeting of the IRE1alpha-TGFbeta signaling loop in pulmonary fibrosis$708,095
R01 · FY2021 · HL
Modulating intrinsic beta cell stress to block diabetes pathogenesis$668,885
R01 · FY2021 · DK
Role of the Unfolded Protein Response in Photoreceptor Degeneration$549,722
R01 · FY2021 · EY
Interrogation of the Roles of Tyrosine Kinases in the Unfolded Protein Response$525,712
R01 · FY2021 · DK
Developing UPR inhibitory KIRAs into oral antidiabetic beta cell-sparing drugs$502,298
R01 · FY2021 · DK · contact PI
Partial Antagonists of IRE1 RNase—‘PAIR’s—to treat Type 1 Diabetes$732,753
U01 · FY2020 · DK · contact PI
Interventional Targeting of the IRE1alpha-TGFbeta signaling loop in pulmonary fibrosis$714,499
R01 · FY2020 · HL
Role of the Unfolded Protein Response in Photoreceptor Degeneration$565,262
R01 · FY2020 · EY
Interrogation of the Roles of Tyrosine Kinases in the Unfolded Protein Response$537,083
R01 · FY2020 · DK
Developing UPR inhibitory KIRAs into oral antidiabetic beta cell-sparing drugs$502,298
R01 · FY2020 · DK · contact PI
Caraballo Diversity Supplement 093019$113,853
R01 · FY2020 · HL
Partial Antagonists of IRE1 RNase—‘PAIR’s—to treat Type 1 Diabetes$751,996
U01 · FY2019 · DK · contact PI
Interventional Targeting of the IRE1alpha-TGFbeta signaling loop in pulmonary fibrosis$721,125
R01 · FY2019 · HL
Role of the Unfolded Protein Response in Photoreceptor Degeneration$562,484
R01 · FY2019 · EY
Interrogation of the Roles of Tyrosine Kinases in the Unfolded Protein Response$548,120
R01 · FY2019 · DK
Developing UPR inhibitory KIRAs into oral antidiabetic beta cell-sparing drugs$502,298
R01 · FY2019 · DK · contact PI
Role of the Unfolded Protein Response in Photoreceptor Degeneration$196,924
R01 · FY2019 · EY
Interrogation of the roles of tyrosine kinases in the unfolded protein response$572,485
R01 · FY2018 · DK
Role of the Unfolded Protein Response in Photoreceptor Degeneration$560,729
R01 · FY2018 · EY
Developing UPR inhibitory KIRAs into oral antidiabetic beta cell-sparing drugs$502,298
R01 · FY2018 · DK · contact PI
Pharmacological Validation of IRE1 for Diabetes Mellitus$539,154
R01 · FY2017 · DK · contact PI
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function$332,850
R01 · FY2017 · DK · contact PI
Drugs to combat ER stress-induced dysfunction of AECIIs/Sheppard$520,335
P01 · FY2016 · HL · contact PI
Pharmacological Validation of IRE1 for Diabetes Mellitus$489,432
R01 · FY2016 · DK · contact PI
Attenuating ER and oxidative stress signaling to reduce cell degeneration in vivo$384,363
R01 · FY2016 · DK · contact PI
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function$332,850
R01 · FY2016 · DK · contact PI
Pharmacological Validation of IRE1 for Diabetes Mellitus$72,656
R01 · FY2016 · DK · contact PI
Pharmacological Validation of IRE1 for Diabetes Mellitus$488,979
R01 · FY2015 · DK · contact PI
Attenuating ER and oxidative stress signaling to reduce cell degeneration in vivo$384,363
R01 · FY2015 · DK · contact PI
Drugs to combat ER stress-induced dysfunction of AECIIs/Sheppard$363,141
P01 · FY2015 · HL · contact PI
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function$332,763
R01 · FY2015 · DK · contact PI
Pharmacological Validation of IRE1 for Diabetes Mellitus$501,998
R01 · FY2014 · DK · contact PI
Drugs to combat ER stress-induced dysfunction of AECIIs/Sheppard$403,045
P01 · FY2014 · HL · contact PI
Attenuating ER and oxidative stress signaling to reduce cell degeneration in vivo$383,251
R01 · FY2014 · DK · contact PI
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function$331,625
R01 · FY2014 · DK · contact PI
"Expanding beta-cell mass"$99,995
U01 · FY2014 · DK
"Expanding beta-cell mass"$1,255,443
U01 · FY2013 · DK
Drugs to combat ER stress-induced dysfunction of AECIIs/Sheppard$398,605
P01 · FY2013 · HL · contact PI
Attenuating ER and oxidative stress signaling to reduce cell degeneration in vivo$380,927
R01 · FY2013 · DK · contact PI
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function$317,823
R01 · FY2013 · DK · contact PI
"Expanding beta-cell mass"$1,301,497
U01 · FY2012 · DK
Drugs to combat ER stress-induced dysfunction of AECIIs/Sheppard$427,067
P01 · FY2012 · HL · contact PI
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function$329,351
R01 · FY2012 · DK · contact PI
"Expanding beta-cell mass"$1,301,500
U01 · FY2011 · DK
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function$329,351
R01 · FY2011 · DK · contact PI
"Expanding beta-cell mass"$1,185,611
U01 · FY2010 · DK
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function$367,092
R01 · FY2010 · DK · contact PI
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function$370,800
R01 · FY2009 · DK · contact PI
HTS to discover drugs effecting protein folding in the endoplasmic reticulum$193,125
R21 · FY2009 · DK · contact PI
HTS to discover drugs effecting protein folding in the endoplasmic reticulum$231,500
R21 · FY2008 · DK · contact PI
Role of the Unfolded Protein Response in Type 2 Diabetes$121,581
K08 · FY2008 · DK · contact PI
New Tools to Measure and Correct Endoplasmic Reticulum Stress in Single Living$2,316,250
DP2 · FY2007 · OD · contact PI
Role of the Unfolded Protein Response in Type 2 Diabetes$121,581
K08 · FY2007 · DK · contact PI
Role of the Unfolded Protein Response in Type 2 Diabetes$121,581
K08 · FY2006 · DK · contact PI
Role of the Unfolded Protein Response in Type 2 Diabetes$122,661
K08 · FY2005 · DK
Role of the Unfolded Protein Response in Type 2 Diabetes$121,581
K08 · FY2004 · DK